Colexa Biosensor

What Colexa Biosensor does

Colexa Biosensor Ltd is a Nigerian in-vitro diagnostics (IVD) manufacturer founded in 2023 as a subsidiary of Codix Group and headquartered in Lagos, Nigeria. The company operates Sub-Saharan Africa's first IVD factory dedicated to blood glucose meters and strips, producing the OnPoint GH82 Blood Glucose Monitoring System — Nigeria's first locally manufactured glucose monitoring solution — and holds the only authorization in Africa to package the WHO pre-qualified STANDARD Q HIV 1/2 Ab 3-Line Test under a Pre-Qualification Change Notification.

The company's product technology relies on a Glucose Dehydrogenase (GDH-FAD) enzyme-based test strip system requiring 0.5 µL capillary blood samples with results delivered in 6 seconds, alongside features such as auto-coding, dual measurement units (mmol/L and mg/dL), strip ejection, and 7/14/30-day averaging. Its Lagos facility has installed capacity of 3.6 million packs of strips annually, scalable to 10.8 million. A sister Codix Group facility, Codix Bio, was commissioned in May 2025 in Sagamu, Ogun State, with capacity for over 147 million test kits per year for HIV, malaria, and hepatitis B/C under the WHO Health Technology Access Pool (H-TAP) programme. Achieved certifications include ISO 13485:2016 (first in Nigeria for IVD manufacturing), ISO 9001:2015, NAFDAC product registration, and EMSON clinical endorsement.

Colexa generates revenue through hardware sales across three primary channels: government procurement (Federal and state health agencies distributing OnPoint systems across primary healthcare centers, supported by a N10.3 billion FEC-approved medical supply package), direct-to-consumer e-commerce via winwell.ng and physical retail through leading health stores, and B2B supply of WHO pre-qualified HIV RDTs to international donor organizations and Nigeria's National AIDS and STI Control Programme (NASCP). The revenue model combines upfront meter sales (bundled with 25 free strips) with recurring revenue from strip refills, and international donor procurement for HIV RDTs.

Name

Colexa Biosensor

Legal name

Colexa Biosensor Ltd

Website

https://colexabiosensor.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

101–250 employees

Short description

Colexa Biosensor Ltd is a Nigerian in-vitro diagnostics manufacturer that produces the OnPoint blood glucose monitoring system and locally packages the WHO pre-qualified STANDARD Q HIV rapid diagnostic test, serving the Nigerian Federal Government, state health programs, healthcare providers, and Sub-Saharan African consumer and donor markets.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics (IVD) Medical Devices

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG)

Keywords

• In-vitro diagnostics manufacturing
• Blood glucose monitoring systems
• HIV rapid diagnostic tests
• Medical device manufacturing
• Diagnostic test strips

Headquarters

HQ city

Lagos

HQ country

Nigeria

HQ region

Africa

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Blood Glucose Monitoring Products: Sale of OnPoint blood glucose meters and test strips to healthcare providers, pharmacies, and directly to consumers. Meters sold with 25 free strips; recurring revenue from strip refills.
2. WHO Pre-qualified HIV RDT Products: Local packaging and distribution of WHO pre-qualified HIV rapid diagnostic tests for national health programs and international donor procurement.
3. E-commerce Retail Sales: Direct consumer sales through online store winwell.ng for blood glucose monitoring products.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

Colexa Biosensor manufactures and distributes the OnPoint GH82 Blood Glucose Monitoring System (meter and test strips) — Nigeria's first locally manufactured blood glucose monitoring solution — and packages the WHO pre-qualified STANDARD Q HIV 1/2 Ab 3-Line Test, being the only facility in Africa authorized to package a WHO pre-qualified HIV rapid diagnostic test. Products serve people living with diabetes, healthcare providers, government health programs, and international donor organizations.

Product overview

Colexa Biosensor is Nigeria and Sub-Saharan Africa's foremost in-vitro diagnostics manufacturer, producing a focused portfolio of diagnostic medical devices. The core offering consists of the OnPoint GH82 Blood Glucose Monitoring System (meter and strips), which represents Africa's first locally manufactured blood glucose monitoring solution, and the WHO pre-qualified STANDARD Q HIV 1/2 Ab 3-Line Test, which Colexa packages locally under WHO authorization. The company operates manufacturing facilities in Lagos and Sagamu, Nigeria, with an installed capacity of 3.6 million packs of strips annually, scalable to 10.8 million.

Differentiator

Problem solved

Functional benefit

Brands

• OnPoint: Nigeria's first locally manufactured blood glucose monitoring system including GH82 Blood Glucose Meter and Test Strips for diabetes management.
• Codeline

Products and services

• OnPoint GH82 Blood Glucose Monitoring System First locally manufactured blood glucose meter in Africa. Uses FAD glucose dehydrogenase (GDH) enzyme system for accurate readings. Features auto-coding, 6-second test time, strip ejector function, alarm reminders, and calculates 7/14/30-day averages. Provides results in both mmol/L and mg/dL units. Includes 2-year warranty with lifetime technical support. For use by people living with diabetes and healthcare professionals.
• OnPoint GH82 Blood Glucose Test Strip Quantitative measurement of glucose in fresh capillary whole blood samples from fingertips, palm, and forearm. For use with OnPoint GH82 meter. Single-use only strips with 6-month shelf life after opening vial. Enables daily self-monitoring of blood glucose for people living with diabetes.
• STANDARD Q HIV 1/2 Ab 3-Line Test Rapid chromatographic immunoassay for qualitative detection of antibodies specific to HIV-1 (including subtype O) and HIV-2 in human serum, plasma, or venous and capillary whole blood. Test time 10-20 minutes. High sensitivity (99.01-100%) and specificity (99.92-100%) across specimen types. Colexa Biosensor is the only facility in Africa authorized to package this WHO pre-qualified test. For use by national HIV testing programs, healthcare providers, and international donor organizations.

Quantifiable outcome

• Federal Government procurement of OnPoint blood glucose monitoring systems for distribution across primary healthcare centers nationwide
• +2 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Ascensia Diabetes Care: Specialist BGM company marketing the Contour portfolio of meters and strips. Direct peer focused exclusively on blood glucose monitoring for diabetes management, with comparable consumer/HCP positioning to Colexa.
• ARKRAY: Japanese manufacturer specializing in blood glucose monitoring devices and diabetes diagnostics. Comparable as a focused BGM manufacturer serving both consumer and clinical markets globally, including emerging markets.
• LifeScan (OneTouch): Pure-play blood glucose monitoring company behind OneTouch meters and strips. Direct competitor in BGM category with similar focus on affordable consumer and clinical glucose testing; comparable product specifications and target use cases to OnPoint.
• Bionime Corporation: Taiwan-based manufacturer of blood glucose monitoring systems with proprietary electrode technology. Comparable mid-sized specialist competing in the same BGM category with a focus on affordability and emerging market distribution.
• SD Biosensor: Korea-based IVD company whose STANDARD Q HIV 1/2 Ab 3-Line Test is licensed to Colexa for local packaging under WHO PQ. Direct partner and peer in rapid diagnostics, with global distribution of WHO-prequalified HIV, malaria, and hepatitis RDTs.
• ACON Laboratories: U.S.-based diagnostics manufacturer producing blood glucose meters, test strips, and rapid diagnostic tests. Comparable as a multi-IVD player with both BGM and RDT portfolios, including HIV and infectious disease tests distributed in Africa.

Broad incumbents

• Abbott Diabetes Care: Markets FreeStyle blood glucose meters and is the dominant player in consumer CGM via FreeStyle Libre. Comparable to Colexa in BGM category but vastly larger, with broader diabetes portfolio and aggressive expansion of CGM into emerging markets.
• Trinity Biotech: Ireland-based IVD company with a portfolio spanning diabetes (hemoglobin A1c), infectious disease, and clinical chemistry. Comparable as a publicly-traded specialist IVD manufacturer with global distribution reach across similar end-markets.
• Roche Diabetes Care: Global leader in blood glucose monitoring through the Accu-Chek brand, with deep clinical evidence and multinational distribution. Directly competes with Colexa's OnPoint in Nigeria and West Africa, but operates as part of a much broader diagnostics and pharma portfolio.

Emerging players

• Nova Biomedical: U.S.-based manufacturer of blood glucose and critical care analyzers for hospital and point-of-care use. Comparable in the BGM and POCT categories with technology overlap, but focused more on the clinical/professional segment than the consumer market Colexa targets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/colexa-biosensor-ltd
• Instagraminstagram.com/colexa.biosensor?igshid=OGQ5ZDc2ODk2ZA==

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Colexa Biosensor